Pre-Clinical Results on Naproxcinod in Models of Muscular Dystrophy Presented

Pre-clinical results on naproxcinod in models of muscular dystrophy presented

Filed under: drug rehab treatment options

The results of the study suggest that naproxcinod may have potential as a safe therapeutic option for the treatment of muscular dystrophies. Naproxcinod treatment at 10 and 21mg/kg resulted in … diagnosis of acute conjunctivitis in-licensed from RPS …
Read more on Marketwire (press release)

 

Bristol-Myers Squibb signs up with another partner for daclatasvir, Merck & Co

Filed under: drug rehab treatment options

US pharma giant Merck & Co (NYSE: MRK) has entered into a non-exclusive agreement with drug major Bristol-Myers Squibb (NYSE: BMY) to conduct a Phase II clinical trial to evaluate the safety and efficacy of a once-daily oral combination regimen …
Read more on The Pharma Letter

 

Multi-Million Dollar Gift Establishes Brain Tumor Center at Methodist – Newswise

Filed under: drug rehab treatment options

The Kenneth R. Peak Brain & Pituitary Tumor Treatment Center will offer personalized neurosurgical and cancer treatment options, and give patients access to novel research studies not available elsewhere. … therapies will include immunotherapy …
Read more on Newswise (press release)

 

Comment: Everything Lansley said about drugs is inaccurate – Politics.co.uk

Filed under: drug rehab treatment options

For many accessing DCRs it is often their step towards treatment. Since 2006 there have been further studies on the impact of these facilities including a 2010 report from the European Monitoring Centre on Drugs and Drug Abuse which support the …
Read more on Politics.co.uk